posted on 2023-08-29, 15:20authored byMarco Magistri, Lanie E. Happ, Jeremy Ramdial, XiaoQing Lu, Vasileios Stathias, Kranthi Kunkalla, Nitin Agarwal, Xiaoyu Jiang, Stephan C. Schürer, Sander R. Dubovy, Jennifer R. Chapman, Francisco Vega, Sandeep Dave, Izidore S. Lossos
Sequencing Quality control (A), Mutational signature (B) and Geneset Sources (C)
Funding
HHS | NIH | National Cancer Institute (NCI)
Anthony Rizzo Families Foundation
Jaime Erin Follicular Lymphoma Research Consortium
History
ARTICLE ABSTRACT
We report systematic application of whole-exome sequencing and CN variations in OAMZL, revealing common alterations in regulation of NFAT signaling pathway that may facilitate identification of new therapies.